STEPHANIE BECKER: Open Payments
NPI 1194204040 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 16 payments from 7 companies in 2025. Trend: 2023 $410 · 2024 $251 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $53 |
| Novo Nordisk Inc | 2 | $49 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| ABBVIE INC. | 2 | $45 |
| Lilly USA, LLC | 3 | $44 |
| Exact Sciences Corporation | 2 | $34 |
| PFIZER INC. | 1 | $14 |
Products named: Ozempic, GARDASIL 9, QULIPTA, MOUNJARO, Cologuard Collection Kit, AREXVY, SHINGRIX, TRELEGY ELLIPTA.
Industry payments across OH — which companies pay providers there.
